Related Experiment Video
Updated: Mar 13, 2026
04:11
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
5.0K
Hepatitis A in Poland in 2014
1National Institute of Public Health – National Institute of Hygiene, Department of Epidemiology
Przeglad Epidemiologiczny
|October 26, 2016
Summary
Hepatitis A cases increased in Poland in 2014, but the overall epidemiological situation remained stable, indicating continued low endemicity. Enhanced surveillance and vaccination efforts, particularly for berry producers, are crucial given international outbreak trends.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Hepatitis A remains a significant public health concern globally.
- Poland is considered a country with low endemicity for Hepatitis A.
- Understanding recent epidemiological trends is vital for effective public health strategies.
Purpose of the Study:
- To assess the epidemiological situation of Hepatitis A in Poland during 2014.
- To analyze trends in Hepatitis A cases in relation to recent years.
- To inform public health policy regarding Hepatitis A surveillance and vaccination.
Main Methods:
- Analysis of data from national bulletins on infectious diseases and vaccinations in Poland for 2014.
- Review of individual case questionnaires and epidemiological investigation reports.
- Data sourced from sanitary-epidemiological stations and the Department of Epidemiology in NIPH-NIH.
Main Results:
- 76 cases of Hepatitis A were registered in Poland in 2014, with an incidence of 0.20 per 100,000 inhabitants.
- Incidence varied regionally, from 0.07 in Dolnosląskie to 0.30 in Małopolskie voivodeships.
- No significant difference in incidence was observed between males and females.
Conclusions:
- Despite a slight increase in cases in 2014, Poland maintains a low endemicity for Hepatitis A.
- Routine surveillance needs enhancement, particularly regarding vaccination status and professional affiliations.
- Targeted vaccination of individuals involved in berry production is recommended due to Poland's export status and international outbreak risks.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
320
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
320